drugset / Trial / NCT00003288

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

NCT00003288

Phase 1 Completed 12 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of tirapazamine plus cyclophosphamide in treating children who have refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Timeline

Start
1998-08
Primary completion
2003-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Subject tirapazamine Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous